Nektar Therapeutics (NKTR.OQ)
NKTR.OQ on NASDAQ Stock Exchange Global Select Market
12.69USD
1 Aug 2013
12.69USD
1 Aug 2013
Price Change (% chg)
$1.48 (+13.20%)
$1.48 (+13.20%)
Prev Close
$11.21
$11.21
Open
$11.33
$11.33
Day's High
$12.77
$12.77
Day's Low
$11.26
$11.26
Volume
759,439
759,439
Avg. Vol
301,445
301,445
52-wk High
$12.94
$12.94
52-wk Low
$5.66
$5.66
About
Nektar Therapeutics is a clinical-stage biopharmaceutical company which develops a pipeline of drug candidates that utilize company platforms. The Company's product pipeline is consisted of early to late stage drug candidates across a number of therapeutic areas, including oncology, pain, anti-infectives, anti-viral and... (more)
Overall
| Beta: | 0.65 |
| Market Cap (Mil.): | $1,295.01 |
| Shares Outstanding (Mil.): | 115.52 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| NKTR.OQ | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 47.13 | 37.76 |
| EPS (TTM): | -1.62 | -- | -- |
| ROI: | -47.12 | -2.58 | 18.76 |
| ROE: | -232.47 | -2.66 | 19.59 |
Competitors
| Price | Change | |
|---|---|---|
| Enzon Pharmaceuticals Inc (ENZN.OQ) | $2.00 | 0.00 |
| NOF CORPORATION (4403.T) | ¥629 | +16.00 |
| Progenics Pharmaceuticals, Inc. (PGNX.OQ) | $5.84 | -0.15 |
| Pfizer Inc. (PFE.N) | $29.11 | -0.12 |
| GlaxoSmithKline plc (GSK.L) | 1,712.50p | +28.50 |
| Sucampo Pharmaceuticals, Inc. (SCMP.OQ) | $6.30 | +0.17 |
| Takeda Pharmaceutical Company Limited (4502.T) | ¥4,625 | +45.00 |
| Bristol Myers Squibb Co. (BMY.N) | $43.99 | +0.75 |
| Bristol Myers Squibb Co. (BMYMP.PK) | -- | -- |
| Roche Holding Ltd. (ROG.VX) | CHF228.00 | -3.50 |
Earnings vs.
Estimates
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Provider: S&P Capital IQ Quantitative Report
|
$69.00
|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: ValuEngine, Inc.
|
$25.00
|
|
Provider: Pechala's Reports
|
$15.00
|
|
Provider: Reuters Investment Profile
|
$20.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

